Author:
Gravesen Charlotte Dahl,Chanchiri Imanl,Kristensen Ida Bruun,Jensen Martin Bang,Harbo Frederik Severin Gråe,Dahlrot Rikke Hedegaard
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Stupp R, Hegi ME, et al. European organisation for research and treatment of cancer brain tumour and radiation oncology groups; national cancer institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–66. https://doi.org/10.1016/S1470-2045(09)70025-7.
2. Diagnostik, udredning og behandling af Lymfoplasmacystisk lymfom/ Waldenström’s macroglobulinæmi, Danske Multidisciplinære Cancer Grupper. 2020. https://www.dmcg.dk/siteassets/kliniske-retningslinjer---skabeloner-og-vejledninger/kliniske-retningslinjer-opdelt-pa-dmcg/dlg/dlg_diag_udr_beh_waldenstroms-macro_admgodk260421.pdf. Accessed on 20 Dec 2020.
3. Castillo JJ, Treon SP. How we manage Bing-Neel syndrome. Br J Haematol. 2019;187(3):277–85. https://doi.org/10.1111/bjh.16167.
4. McKinnon C, Nandhabalan M, et al. Glioblastoma: clinical presentation, diagnosis, and management. BMJ. 2021;14(374): n1560. https://doi.org/10.1136/bmj.n1560.
5. Simon L, Fitsiori A, Lema R, et al. Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO). Haematologica. 2015;100(12):1587–94. https://doi.org/10.3324/haematol.2015.133744.